Literature DB >> 27261910

Bronchoscopy: Diagnostic and Therapeutic for Non-Small Cell Lung Cancer.

Thomas L Bauer1, David B Berkheim2.   

Abstract

The bronchoscope has gone through much advancement from its origin as a thin metal tube. It has become a highly sophisticated tool for clinicians. Both rigid and the flexible bronchoscopes are invaluable in the diagnosis and treatment of non-small cell lung cancer. Treatment of this disease process hinges on accurate diagnosis and lymph node staging. Technologies, such as endobronchial ultrasound, navigational bronchoscopy, and autofluorescence, have improved efficacy of endobronchial diagnosis and sample collection. If a patient is not a candidate for surgery and has a complication from a centrally located mass, the bronchoscope has been used to deliver palliative therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablative therapies; Airway stents; Autofluorescence; Bronchoscopy; Endobronchial ultrasound; Navigational bronchoscopy

Mesh:

Year:  2016        PMID: 27261910     DOI: 10.1016/j.soc.2016.02.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  5 in total

1.  Dexmedetomidine plus sufentanil for pediatric flexible bronchoscopy: A retrospective clinical trial.

Authors:  Xiujing Dang; Weidong Hu; Zhendong Yang; Shiyu Su
Journal:  Oncotarget       Date:  2017-06-20

2.  The efficacy of dexmedetomidine-remifentanil versus dexmedetomidine-propofol in children undergoing flexible bronchoscopy: A retrospective trial.

Authors:  Hongquan Zhang; Baojun Fang; Wenjing Zhou
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

3.  Short- and long-term outcomes in elderly patients with locally advanced non-small-cell lung cancer treated using video-assisted thoracic surgery lobectomy.

Authors:  Like Zhang
Journal:  Ther Clin Risk Manag       Date:  2018-11-08       Impact factor: 2.423

4.  CircRNA 0009043 suppresses non-small-cell lung cancer development via targeting the miR-148a-3p/DNAJB4 axis.

Authors:  Kelin She; Shaoqi Yu; Shushuai He; Wen Wang; Biao Chen
Journal:  Biomark Res       Date:  2022-08-16

5.  Nebulized dexmedetomidine-lidocaine inhalation as a premedication for flexible bronchoscopy: a randomized trial.

Authors:  Wei Gu; Meiying Xu; Huijie Lu; Qi Huang; Jingxiang Wu
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.